(“the Company”) reported consolidated revenues of Baht 499.1 million, increased by 15.6% compared with quarterly on quarterly (QoQ). The Company’s gross profit demonstrated at 33.6% to sales value

like to clarify operating performance of the Company three-month for the Quarter 3/2017 ended September 30, 2017 are as follows : Statement of Income Total Revenue The company earned THB 258.0 MB in Q3

Company”) reported consolidated revenues of Baht 496.9 million, decreased by 12.0% compared to quarterly on quarterly (QoQ). The Company’s gross profit was at 31.7% to sales value, declined from QoQ which

enhanced to 28% 9M'2016 9M'2017 % change million Baht million Baht y-on-y Sales and service income 20,691 23,720 14.6% EBITDA 5,679 6,626 16.7% Net profit 2,473 2,823 14.1% Normalized net profit (NNP)* 1,966

: Higher biomass cost. As a result, the gross profit margin dropped in the consolidate income statement from 21% to 16% in 2017. World sugar price volatility At the beginning of 2017, world sugar price has

Public Company Limited (“the Company”) would like to report on Management Discussion and Analysis from the Separate and Consolidated Financial Statements of the year ended December 31, 2017. The details

institution under the Law on Loan Interest of Financial Institutions or a financial institution under foreign law; (2) an agreement having characteristics comparable to the assets under (1) in accordance with

the Law on Loan Interest of Financial Institutions or a financial institution under foreign law; (2) an agreement having characteristics comparable to the assets under (1) in accordance with the Shariah

being a financial institution under the Law on Loan Interest of Financial Institutions or a financial institution under foreign law; (2) an agreement having characteristics comparable to the assets under

Company Profile - DOD BIOTECH PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 28 August 2022 21:45 ​ ​ Company Profile DOD BIOTECH PUBLIC COMPANY LIMITED Please